Citation Impact
Citing Papers
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
2009 StandoutScience
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2008 Standout
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
2004 Standout
The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study
2010
Gonadoblastoma and selected other aspects of gonadal pathology in young patients with disorders of sex development
2014
Cytosolic Action of Thyroid Hormone Leads to Induction of Hypoxia-Inducible Factor-1α and Glycolytic Genes
2005
Effect of Two Years of Growth Hormone and Insulin-Like Growth Factor-I Suppression on Prostate Diseases in Acromegalic Patients1
2000
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
CAR and PXR: Xenosensors of endocrine disrupters?
2005
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects.
1989
Harmless Herbs? A Review of the Recent Literature
1998 Standout
Virilization in Bilateral Macronodular Adrenal Hyperplasia Controlled by Luteinizing Hormone
2003
The Risk–Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
2002 Standout
Cushing's syndrome
2015 Standout
Phytoestrogens: a review of the present state of research
2003
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
Phytotherapy in the treatment of benign prostatic hyperplasia: an update
1999
Discrimination of zone-specific spectral signatures in normal human prostate using Raman spectroscopy
2010
The development of androgen-independent prostate cancer
2001 Standout
Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome
2006
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Serenoa repens for benign prostatic hyperplasia
2002
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine–metabolic and ultrasonographic differences
2002
Lack of linear relationship between hyperinsulinaemia and hyperandrogenism
1992
Comparison of phytotherapy (Permixon®) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patients
1996
Using Raman spectroscopy to characterize biological materials
2016 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation
2005
Polycystic Ovary Syndrome
1995 Standout
A Review of 12 Commonly Used Medicinal Herbs
1998
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Magnetic Resonance Imaging of the Brain in Diabetes
2004
Acne vulgaris
2011 Standout
Assessment of androgens in women with adult‐onset acne
2007
Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?
2002
Fetal Programming of Polycystic Ovary Syndrome by Androgen Excess: Evidence from Experimental, Clinical, and Genetic Association Studies
2006
Nutrition, hormones, and breast cancer: Is insulin the missing link?
1996
Polycystic Ovary Syndrome
2005 Standout
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Consensus Statement on Management of Intersex Disorders
2006 Standout
Incidentally Discovered Adrenal Masses*
1995
Pancreatic Cancer
2010 Standout
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
2016 Standout
Risk of dementia in diabetes mellitus: a systematic review
2005 Standout
Serenoa repensfor benign prostatic hyperplasia
2009
Interaction of sex steroids and prolactin on phosphatases, transaminases, and citric acid in the ventral prostate of male albino rats
1987
Polycystic ovary syndrome
2016 Standout
Effect of Growth Hormone (GH) and Insulin-Like Growth Factor I on Prostate Diseases: An Ultrasonographic and Endocrine Study in Acromegaly, GH Deficiency, and Healthy Subjects
1999
Effect of endogenous and exogenous hormones on testicular cancer: the epidemiological evidence
2013
Eating Patterns and Risk of Colon Cancer
1998 Standout
Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine
2008
Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
2009
Birth weight and age at menarche in patients with polycystic ovary syndrome or diminished ovarian reserve, in a retrospective cohort
2003
Gender Change in 46,XY Persons with 5α-Reductase-2 Deficiency and 17β-Hydroxysteroid Dehydrogenase-3 Deficiency
2005
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
A study of the reliability and comparative validity of the cardia dietary history.
1994
Association of the (TAAAA)n Repeat Polymorphism in the Sex Hormone-Binding Globulin (SHBG) Gene with Polycystic Ovary Syndrome and Relation to SHBG Serum Levels
2003
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
1998 Standout
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Study of 202 Natural, Synthetic, and Environmental Chemicals for Binding to the Androgen Receptor
2003
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
The hypothalamus and reproduction
1975 StandoutNobel
Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology
2000 Standout
Use of Synthetic Luteinizing Hormone-Releasing Hormone in Treatment of Oligospermic Men: A Preliminary Report
1975 StandoutNobel
Treatment of Idiopathic Normogonadotropic Oligoasthenospermia with Synthetic Luteinizing Hormone-Releasing Hormone
1976 StandoutNobel
Combination therapy in combating cancer
2017 Standout
Collocation of androgen receptor gene mutations in prostate cancer.
2001
Thyroid Hormone Regulation of Metabolism
2014 Standout
Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne
2009
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Drug-Induced Male Sexual Dysfunction
1988
Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.
2001
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors
2007
General Cardiovascular Risk Profile for Use in Primary Care
2008 Standout
The Value of the Low-Dose Dexamethasone Suppression Test in the Differential Diagnosis of Hyperandrogenism in Women
2003
Role of Hormones in Pilosebaceous Unit Development
2000
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
2007
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study
1994 Standout
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of F Sciarra being referenced
Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
2003
Two different pathogenetic mechanisms may play a role in acne and in hirsutism
1993
Insulin-Like Growth Factor-I and -II in Human Benign Prostatic Hyperplasia: Relationship with Binding Proteins 2 and 3 and Androgens
1998
Hyperandrogenism in the Adolescent Female
1998
Regional distribution of epidermal growth factor, testosterone and dihydrotestosterone in benign prostatic hyperplasia tissue
1995
A clinician looks at androgen resistance
1996
Advanced Prostatic Cancer: Clinical and Hormonal Response to Flutamide in Patients Pretreated with LHRH Analogue andCyproterone Acetate
1990
Evidence that Serenoa repens Extract Displays an Antiestrogenic Activity in Prostatic Tissue of Benign Prostatic Hypertrophy Patients
1992
Steroidal and non-steroidal factors in plasma sex hormone binding globulin regulation
1992
Androgenic and antiandrogenic control on epidermal growth factor, epidermal growth factor receptor, and androgen receptor expression in human prostate cancer cell line LNCaP
1995
Antiandrogens: Clinical applications
1990
FAMILIAL MALE PSEUDOHERMAPHRODITISM WITH GYNAECOMASTIA DUE TO 17β‐HYDROXYSTEROID DEHYDROGENASE DEFICIENCY. A REPORT OF 3 CASES
1985
Change in cardiovascular risk factors during a 10-year community intervention program.
1997
Is hirsutism an evolving syndrome?
1983
INFLUENCE OF HYPERPROLACTINAEMIA DUE TO METOCLOPRAMIDE ON GONADAL FUNCTION IN MEN
1978
Plasma testosterone and androstenedione after orchiectomy in prostatic adenocarcinoma
1973
Androgen-secreting adrenal tumors.
1995
The hormone pattern in a case of arrhenoblastoma
1981
Evaluation of Relationship between Plasma Testosterone and Human Seminal Citric Acid
1972